Wessels JA - Search Results

1

Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.

Wessels JA, Huizinga TW, Guchelaar HJ. Wessels JA, et al. Rheumatology (Oxford). 2008 Mar;47(3):249-55. doi: 10.1093/rheumatology/kem279. Epub 2007 Nov 28. Rheumatology (Oxford). 2008. PMID: 18045808 Review.

2

Comment on: The pharmacogenetics of methotrexate.

van der Kooij SM, Wessels JA, Huizinga TW, Guchelaar HJ. van der Kooij SM, et al. Among authors: wessels ja. Rheumatology (Oxford). 2008 Apr;47(4):557; author reply 5557-8. doi: 10.1093/rheumatology/kem386. Epub 2008 Jan 25. Rheumatology (Oxford). 2008. PMID: 18222982 No abstract available.

3

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.

Albers HM, Wessels JA, van der Straaten RJ, Brinkman DM, Suijlekom-Smit LW, Kamphuis SS, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, Ten Cate R, Guchelaar HJ. Albers HM, et al. Among authors: wessels ja. Arthritis Rheum. 2009 Jan 15;61(1):46-51. doi: 10.1002/art.24087. Arthritis Rheum. 2009. PMID: 19116975 Free article.

4

Pharmacogenetics in treatment of rheumatoid arthritis.

Kooloos WM, Huizinga TW, Guchelaar HJ, Wessels JA. Kooloos WM, et al. Among authors: wessels ja. Curr Pharm Des. 2010;16(2):164-75. doi: 10.2174/138161210790112764. Curr Pharm Des. 2010. PMID: 20205662 Review.

5

Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.

Wessels JA, Kooloos WM, De Jonge R, De Vries-Bouwstra JK, Allaart CF, Linssen A, Collee G, De Sonnaville P, Lindemans J, Huizinga TW, Guchelaar HJ. Wessels JA, et al. Arthritis Rheum. 2006 Sep;54(9):2830-9. doi: 10.1002/art.22032. Arthritis Rheum. 2006. PMID: 16947783 Free article. Clinical Trial.

6

Genetic markers of treatment response in rheumatoid arthritis.

Wesoly J, Wessels JA, Guchelaar HJ, Huizinga TW. Wesoly J, et al. Among authors: wessels ja. Curr Rheumatol Rep. 2006 Oct;8(5):369-77. doi: 10.1007/s11926-006-0068-5. Curr Rheumatol Rep. 2006. PMID: 16973111 Review.

7

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.

Wessels JA, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF, Huizinga TW, Guchelaar HJ; Pharmacogenetics Collaborative Research Group. Wessels JA, et al. Arthritis Rheum. 2007 Jun;56(6):1765-75. doi: 10.1002/art.22640. Arthritis Rheum. 2007. PMID: 17530705 Free article.

8

Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.

Kooloos WM, Wessels JA, van der Straaten T, Allaart CF, Huizinga TW, Guchelaar HJ. Kooloos WM, et al. Among authors: wessels ja. Pharmacogenomics. 2010 Feb;11(2):163-75. doi: 10.2217/pgs.09.139. Pharmacogenomics. 2010. PMID: 20136356

9

Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT.

ten Brink MH, Wessels JA, den Hartigh J, van der Straaten T, von dem Borne PA, Guchelaar HJ, Zwaveling J. ten Brink MH, et al. Among authors: wessels ja. Bone Marrow Transplant. 2012 Feb;47(2):190-5. doi: 10.1038/bmt.2011.55. Epub 2011 Mar 28. Bone Marrow Transplant. 2012. PMID: 21441958

10

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.

Pander J, Wessels JAM, Gelderblom H, van der Straaten T, Punt CJA, Guchelaar HJ. Pander J, et al. Ann Oncol. 2011 May;22(5):1147-1153. doi: 10.1093/annonc/mdq572. Epub 2010 Nov 3. Ann Oncol. 2011. PMID: 21048041 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters